Adial Pharmaceuticals Announces Private Placement of Common Stock at $4.00 Per Share and Cash Exercise of Stock Options

NEXT STORY
BW Health Group Introduces Kander™ Patient Feedback System
PREV STORY
CHD Board Chair Robert F. Kennedy, Jr.’s latest book, ‘The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health,’ hits bookstores November 16
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche announces FDA approval of Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer

author_avatar
NASDAQ Market News

Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Vir Biotechnology Appoints Jeffrey Hatfield to its Board of Directors

author_avatar
NASDAQ Market News